This report aims to provide a comprehensive presentation of the global market for Kidney Transplant Rejection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Transplant Rejection Therapeutics. This report contains market size and forecasts of Kidney Transplant Rejection Therapeutics in global, including the following market information:
- Global Kidney Transplant Rejection Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Kidney Transplant Rejection Therapeutics Market Sales, 2018-2023, 2024-2030, (K Pcs)
- Global top five Kidney Transplant Rejection Therapeutics companies in 2022 (%)
The global Kidney Transplant Rejection Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Azathioprine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Kidney Transplant Rejection Therapeutics include CSL Limited, Digna Biotech, S.L., GlaxoSmithKline Plc, Grifols, S.A., Hansa Medical AB, Kyowa Hakko Kirin, Mabtech Limited, Magnus Life Ltd and Noorik Biopharmaceuticals AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Kidney Transplant Rejection Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Transplant Rejection Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Kidney Transplant Rejection Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Azathioprine
- Cortina
- Cyclophosphamide
- Cyclosporin A
- Other
Global Kidney Transplant Rejection Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Kidney Transplant Rejection Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinic
- ASCs
- Others
Global Kidney Transplant Rejection Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Kidney Transplant Rejection Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Kidney Transplant Rejection Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Kidney Transplant Rejection Therapeutics revenues share in global market, 2022 (%)
- Key companies Kidney Transplant Rejection Therapeutics sales in global market, 2018-2023 (Estimated), (K Pcs)
- Key companies Kidney Transplant Rejection Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CSL Limited
- Digna Biotech, S.L.
- GlaxoSmithKline Plc
- Grifols, S.A.
- Hansa Medical AB
- Kyowa Hakko Kirin
- Mabtech Limited
- Magnus Life Ltd
- Noorik Biopharmaceuticals AG
- Novartis AG
- Opsona Therapeutics Limited
- OSE Immunotherapeutics
- Pharmicell
- Pharming Group N.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney Transplant Rejection Therapeutics, market overview.
Chapter 2: Global Kidney Transplant Rejection Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Kidney Transplant Rejection Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Transplant Rejection Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Kidney Transplant Rejection Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Kidney Transplant Rejection Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Transplant Rejection Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Transplant Rejection Therapeutics Overall Market Size
2.1 Global Kidney Transplant Rejection Therapeutics Market Size: 2022 VS 2030
2.2 Global Kidney Transplant Rejection Therapeutics Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Kidney Transplant Rejection Therapeutics Sales: 2018-2030
3 Company Landscape
3.1 Top Kidney Transplant Rejection Therapeutics Players in Global Market
3.2 Top Global Kidney Transplant Rejection Therapeutics Companies Ranked by Revenue
3.3 Global Kidney Transplant Rejection Therapeutics Revenue by Companies
3.4 Global Kidney Transplant Rejection Therapeutics Sales by Companies
3.5 Global Kidney Transplant Rejection Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Kidney Transplant Rejection Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Kidney Transplant Rejection Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Transplant Rejection Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Kidney Transplant Rejection Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney Transplant Rejection Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Kidney Transplant Rejection Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Azathioprine
4.1.3 Cortina
4.1.4 Cyclophosphamide
4.1.5 Cyclosporin A
4.1.6 Other
4.2 By Type - Global Kidney Transplant Rejection Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Kidney Transplant Rejection Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Kidney Transplant Rejection Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
4.3 By Type - Global Kidney Transplant Rejection Therapeutics Sales & Forecasts
4.3.1 By Type - Global Kidney Transplant Rejection Therapeutics Sales, 2018-2023
4.3.2 By Type - Global Kidney Transplant Rejection Therapeutics Sales, 2024-2030
4.3.3 By Type - Global Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
4.4 By Type - Global Kidney Transplant Rejection Therapeutics Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Transplant Rejection Therapeutics Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 ASCs
5.1.5 Others
5.2 By Application - Global Kidney Transplant Rejection Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Kidney Transplant Rejection Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Kidney Transplant Rejection Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
5.3 By Application - Global Kidney Transplant Rejection Therapeutics Sales & Forecasts
5.3.1 By Application - Global Kidney Transplant Rejection Therapeutics Sales, 2018-2023
5.3.2 By Application - Global Kidney Transplant Rejection Therapeutics Sales, 2024-2030
5.3.3 By Application - Global Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
5.4 By Application - Global Kidney Transplant Rejection Therapeutics Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Kidney Transplant Rejection Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Kidney Transplant Rejection Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Kidney Transplant Rejection Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Kidney Transplant Rejection Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
6.3 By Region - Global Kidney Transplant Rejection Therapeutics Sales & Forecasts
6.3.1 By Region - Global Kidney Transplant Rejection Therapeutics Sales, 2018-2023
6.3.2 By Region - Global Kidney Transplant Rejection Therapeutics Sales, 2024-2030
6.3.3 By Region - Global Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Kidney Transplant Rejection Therapeutics Revenue, 2018-2030
6.4.2 By Country - North America Kidney Transplant Rejection Therapeutics Sales, 2018-2030
6.4.3 US Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.4.4 Canada Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.4.5 Mexico Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Kidney Transplant Rejection Therapeutics Revenue, 2018-2030
6.5.2 By Country - Europe Kidney Transplant Rejection Therapeutics Sales, 2018-2030
6.5.3 Germany Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5.4 France Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5.5 U.K. Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5.6 Italy Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5.7 Russia Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5.8 Nordic Countries Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.5.9 Benelux Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Kidney Transplant Rejection Therapeutics Revenue, 2018-2030
6.6.2 By Region - Asia Kidney Transplant Rejection Therapeutics Sales, 2018-2030
6.6.3 China Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.6.4 Japan Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.6.5 South Korea Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.6.6 Southeast Asia Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.6.7 India Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Kidney Transplant Rejection Therapeutics Revenue, 2018-2030
6.7.2 By Country - South America Kidney Transplant Rejection Therapeutics Sales, 2018-2030
6.7.3 Brazil Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.7.4 Argentina Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Sales, 2018-2030
6.8.3 Turkey Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.8.4 Israel Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.8.5 Saudi Arabia Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
6.8.6 UAE Kidney Transplant Rejection Therapeutics Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 CSL Limited
7.1.1 CSL Limited Company Summary
7.1.2 CSL Limited Business Overview
7.1.3 CSL Limited Kidney Transplant Rejection Therapeutics Major Product Offerings
7.1.4 CSL Limited Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 CSL Limited Key News & Latest Developments
7.2 Digna Biotech, S.L.
7.2.1 Digna Biotech, S.L. Company Summary
7.2.2 Digna Biotech, S.L. Business Overview
7.2.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Major Product Offerings
7.2.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 Digna Biotech, S.L. Key News & Latest Developments
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Company Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Major Product Offerings
7.3.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Plc Key News & Latest Developments
7.4 Grifols, S.A.
7.4.1 Grifols, S.A. Company Summary
7.4.2 Grifols, S.A. Business Overview
7.4.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Major Product Offerings
7.4.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 Grifols, S.A. Key News & Latest Developments
7.5 Hansa Medical AB
7.5.1 Hansa Medical AB Company Summary
7.5.2 Hansa Medical AB Business Overview
7.5.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Major Product Offerings
7.5.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Hansa Medical AB Key News & Latest Developments
7.6 Kyowa Hakko Kirin
7.6.1 Kyowa Hakko Kirin Company Summary
7.6.2 Kyowa Hakko Kirin Business Overview
7.6.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Major Product Offerings
7.6.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Kyowa Hakko Kirin Key News & Latest Developments
7.7 Mabtech Limited
7.7.1 Mabtech Limited Company Summary
7.7.2 Mabtech Limited Business Overview
7.7.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Major Product Offerings
7.7.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 Mabtech Limited Key News & Latest Developments
7.8 Magnus Life Ltd
7.8.1 Magnus Life Ltd Company Summary
7.8.2 Magnus Life Ltd Business Overview
7.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Major Product Offerings
7.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Magnus Life Ltd Key News & Latest Developments
7.9 Noorik Biopharmaceuticals AG
7.9.1 Noorik Biopharmaceuticals AG Company Summary
7.9.2 Noorik Biopharmaceuticals AG Business Overview
7.9.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Major Product Offerings
7.9.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Noorik Biopharmaceuticals AG Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Kidney Transplant Rejection Therapeutics Major Product Offerings
7.10.4 Novartis AG Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Novartis AG Key News & Latest Developments
7.11 Opsona Therapeutics Limited
7.11.1 Opsona Therapeutics Limited Company Summary
7.11.2 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Business Overview
7.11.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Major Product Offerings
7.11.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.11.5 Opsona Therapeutics Limited Key News & Latest Developments
7.12 OSE Immunotherapeutics
7.12.1 OSE Immunotherapeutics Company Summary
7.12.2 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Business Overview
7.12.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Major Product Offerings
7.12.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.12.5 OSE Immunotherapeutics Key News & Latest Developments
7.13 Pharmicell
7.13.1 Pharmicell Company Summary
7.13.2 Pharmicell Kidney Transplant Rejection Therapeutics Business Overview
7.13.3 Pharmicell Kidney Transplant Rejection Therapeutics Major Product Offerings
7.13.4 Pharmicell Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.13.5 Pharmicell Key News & Latest Developments
7.14 Pharming Group N.V.
7.14.1 Pharming Group N.V. Company Summary
7.14.2 Pharming Group N.V. Business Overview
7.14.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Major Product Offerings
7.14.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales and Revenue in Global (2018-2023)
7.14.5 Pharming Group N.V. Key News & Latest Developments
8 Global Kidney Transplant Rejection Therapeutics Production Capacity, Analysis
8.1 Global Kidney Transplant Rejection Therapeutics Production Capacity, 2018-2030
8.2 Kidney Transplant Rejection Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Transplant Rejection Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney Transplant Rejection Therapeutics Supply Chain Analysis
10.1 Kidney Transplant Rejection Therapeutics Industry Value Chain
10.2 Kidney Transplant Rejection Therapeutics Upstream Market
10.3 Kidney Transplant Rejection Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney Transplant Rejection Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Kidney Transplant Rejection Therapeutics in Global Market
Table 2. Top Kidney Transplant Rejection Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Kidney Transplant Rejection Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Kidney Transplant Rejection Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global Kidney Transplant Rejection Therapeutics Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Kidney Transplant Rejection Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Kidney Transplant Rejection Therapeutics Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Kidney Transplant Rejection Therapeutics Product Type
Table 9. List of Global Tier 1 Kidney Transplant Rejection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Transplant Rejection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Kidney Transplant Rejection Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Kidney Transplant Rejection Therapeutics Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), 2018-2023
Table 15. By Type - Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Kidney Transplant Rejection Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Kidney Transplant Rejection Therapeutics Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), 2018-2023
Table 20. By Application - Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Kidney Transplant Rejection Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Kidney Transplant Rejection Therapeutics Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), 2018-2023
Table 25. By Region - Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), 2024-2030
Table 26. By Country - North America Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Sales, (K Pcs), 2024-2030
Table 46. CSL Limited Company Summary
Table 47. CSL Limited Kidney Transplant Rejection Therapeutics Product Offerings
Table 48. CSL Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. CSL Limited Key News & Latest Developments
Table 50. Digna Biotech, S.L. Company Summary
Table 51. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Offerings
Table 52. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Digna Biotech, S.L. Key News & Latest Developments
Table 54. GlaxoSmithKline Plc Company Summary
Table 55. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Offerings
Table 56. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. GlaxoSmithKline Plc Key News & Latest Developments
Table 58. Grifols, S.A. Company Summary
Table 59. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Offerings
Table 60. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Grifols, S.A. Key News & Latest Developments
Table 62. Hansa Medical AB Company Summary
Table 63. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Offerings
Table 64. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Hansa Medical AB Key News & Latest Developments
Table 66. Kyowa Hakko Kirin Company Summary
Table 67. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Offerings
Table 68. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Kyowa Hakko Kirin Key News & Latest Developments
Table 70. Mabtech Limited Company Summary
Table 71. Mabtech Limited Kidney Transplant Rejection Therapeutics Product Offerings
Table 72. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Mabtech Limited Key News & Latest Developments
Table 74. Magnus Life Ltd Company Summary
Table 75. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Offerings
Table 76. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Magnus Life Ltd Key News & Latest Developments
Table 78. Noorik Biopharmaceuticals AG Company Summary
Table 79. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Offerings
Table 80. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Noorik Biopharmaceuticals AG Key News & Latest Developments
Table 82. Novartis AG Company Summary
Table 83. Novartis AG Kidney Transplant Rejection Therapeutics Product Offerings
Table 84. Novartis AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Novartis AG Key News & Latest Developments
Table 86. Opsona Therapeutics Limited Company Summary
Table 87. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Offerings
Table 88. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Opsona Therapeutics Limited Key News & Latest Developments
Table 90. OSE Immunotherapeutics Company Summary
Table 91. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Offerings
Table 92. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. OSE Immunotherapeutics Key News & Latest Developments
Table 94. Pharmicell Company Summary
Table 95. Pharmicell Kidney Transplant Rejection Therapeutics Product Offerings
Table 96. Pharmicell Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Pharmicell Key News & Latest Developments
Table 98. Pharming Group N.V. Company Summary
Table 99. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Offerings
Table 100. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Pharming Group N.V. Key News & Latest Developments
Table 102. Kidney Transplant Rejection Therapeutics Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 103. Global Kidney Transplant Rejection Therapeutics Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Kidney Transplant Rejection Therapeutics Production by Region, 2018-2023 (K Pcs)
Table 105. Global Kidney Transplant Rejection Therapeutics Production by Region, 2024-2030 (K Pcs)
Table 106. Kidney Transplant Rejection Therapeutics Market Opportunities & Trends in Global Market
Table 107. Kidney Transplant Rejection Therapeutics Market Drivers in Global Market
Table 108. Kidney Transplant Rejection Therapeutics Market Restraints in Global Market
Table 109. Kidney Transplant Rejection Therapeutics Raw Materials
Table 110. Kidney Transplant Rejection Therapeutics Raw Materials Suppliers in Global Market
Table 111. Typical Kidney Transplant Rejection Therapeutics Downstream
Table 112. Kidney Transplant Rejection Therapeutics Downstream Clients in Global Market
Table 113. Kidney Transplant Rejection Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Kidney Transplant Rejection Therapeutics Segment by Type in 2022
Figure 2. Kidney Transplant Rejection Therapeutics Segment by Application in 2022
Figure 3. Global Kidney Transplant Rejection Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Kidney Transplant Rejection Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Kidney Transplant Rejection Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. Kidney Transplant Rejection Therapeutics Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Transplant Rejection Therapeutics Revenue in 2022
Figure 9. By Type - Global Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 11. By Type - Global Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 12. By Type - Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Application - Global Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 16. By Application - Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 20. By Region - Global Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 21. By Country - North America Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 22. By Country - North America Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 23. US Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 28. Germany Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. France Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 37. China Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. India Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 43. By Country - South America Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 44. Brazil Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Kidney Transplant Rejection Therapeutics Sales Market Share, 2018-2030
Figure 48. Turkey Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Kidney Transplant Rejection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 52. Global Kidney Transplant Rejection Therapeutics Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Kidney Transplant Rejection Therapeutics by Region, 2022 VS 2030
Figure 54. Kidney Transplant Rejection Therapeutics Industry Value Chain
Figure 55. Marketing Channels
